CP and parkinsonism due to ATP13A2 deficiency: Lifetime risks between 0.04 and 0.07 per 100,000 in all datasets were found for Kufor-Rakeb syndrome (KRS; MIM ID # 606693) and aceruloplasminemia (ACP; MIM ID # 604290) based on pathogenic variants in ATP13A2 and CP, respectively (Figures 1, 2, Table 2).